Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer

14 Feb 2025

Abstract excerpt

DNA methyltransferase 3A (DNMT3A) has been associated with the occurrence or progression of various tumors, including gastric cancer. However, the role of DNMT3A in the efficacy of immune-cell infiltration in the tumor microenvironment and immunotherapy in gastric cancer remains less explored. DNMT3A expression level was analyzed using TIMER 2.0, Sangerbox 3.0, and The Cancer Genome Atlas database and further...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39960919
DOI: 10.1097/md.0000000000041578

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancerPMID 39960919Read ↗

Clinical significance of the expression of DNA methyltransferase proteins in gastric cancerSemantic proximity Read ↗

DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancerSemantic proximity Read ↗

Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy responseSemantic proximity Read ↗

Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer.Semantic proximity Read ↗

DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

DNA methyltransferase 3a rs1550117 genetic polymorphism predicts poor survival in gastric cancer patients.Semantic proximity Read ↗

N6-methyladenosine demethylase FTO serves as an indicator for predicting prognosis and immunotherapy response in individuals with gastric cancerSemantic proximity Read ↗

Bioinformatics analysis of DNMT1 expression and its role in head and neck squamous cell carcinoma prognosis.Semantic proximity Read ↗

An updated meta-analysis investigating the association between DNMTs gene polymorphism andgastric cancer risk.Semantic proximity Read ↗

SNHG3/miR-148a-3p Axis–mediated High Expression of DNMT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular CarcinomaSemantic proximity Read ↗

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric CancerSemantic proximity Read ↗

Genome‐wide identification of Epstein‐Barr virus–driven promoter methylation profiles of human genes in gastric cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.